417 related articles for article (PubMed ID: 30255690)
1. Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells.
Marbaniang C; Kma L
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2377-2390. PubMed ID: 30255690
[TBL] [Abstract][Full Text] [Related]
2. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.
Chen JQ; Russo J
Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
[TBL] [Abstract][Full Text] [Related]
5. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea.
DeBerardinis RJ
Genet Med; 2008 Nov; 10(11):767-77. PubMed ID: 18941420
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and the Warburg Effect: new players in an old arena.
Gao P; Sun L; He X; Cao Y; Zhang H
Curr Gene Ther; 2012 Aug; 12(4):285-91. PubMed ID: 22856603
[TBL] [Abstract][Full Text] [Related]
7. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
Levine AJ; Puzio-Kuter AM
Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
9. Links between metabolism and cancer.
Dang CV
Genes Dev; 2012 May; 26(9):877-90. PubMed ID: 22549953
[TBL] [Abstract][Full Text] [Related]
10. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
11. Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy.
Ghasemishahrestani Z; Melo Mattos LM; Tilli TM; Santos ALSD; Pereira MD
Curr Med Chem; 2021; 28(18):3514-3534. PubMed ID: 32814521
[TBL] [Abstract][Full Text] [Related]
12. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
13. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
[TBL] [Abstract][Full Text] [Related]
14. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Kent OA; Mendell JT
Oncogene; 2006 Oct; 25(46):6188-96. PubMed ID: 17028598
[TBL] [Abstract][Full Text] [Related]
15. The pivotal role of MicroRNAs in glucose metabolism in cancer.
Taefehshokr S; Taefehshokr N; Hemmat N; Hajazimian S; Isazadeh A; Dadebighlu P; Baradaran B
Pathol Res Pract; 2021 Jan; 217():153314. PubMed ID: 33341548
[TBL] [Abstract][Full Text] [Related]
16. Post-translational modifications and the Warburg effect.
Hitosugi T; Chen J
Oncogene; 2014 Aug; 33(34):4279-85. PubMed ID: 24096483
[TBL] [Abstract][Full Text] [Related]
17. Metabolic pathways promoting cancer cell survival and growth.
Boroughs LK; DeBerardinis RJ
Nat Cell Biol; 2015 Apr; 17(4):351-9. PubMed ID: 25774832
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cancer metabolism by oncogenes and tumor suppressors.
Iurlaro R; León-Annicchiarico CL; Muñoz-Pinedo C
Methods Enzymol; 2014; 542():59-80. PubMed ID: 24862260
[TBL] [Abstract][Full Text] [Related]
19. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
Dang CV; Le A; Gao P
Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
[TBL] [Abstract][Full Text] [Related]
20. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
